Delivery Order SPE2DB22D3301-SPE2DB24FX3RB
Award Date 10/13/23
Potential Completion Date 11/3/23
Potential Value $106K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a $6,928.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 110 mg Artesunate vials, with an ultimate completion date of May 23, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was issued to the contractor's Corporate Office...
- The Defense Logistics Agency issued a $16,477.32 delivery order to Amerisourcebergen Drug Corp on May 8, 2026, for 110 mg artesunate vials, with final delivery due May 11, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying the Department of Defense and federal healthcare systems. The company holds a single-award indefinite delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,244 vials of 110 mg Artesunate. The award has a ceiling value of $33,451.08 and a period of performance extending through May 15, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, with a ceiling value of $66,707.37 for Artesunate 110 mg vials. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply to military healthcare systems worldwide. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 13, 2026, for Artesunate 110 mg vials with a ceiling value of $20,427.24.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 9, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $19,816 to Amerisourcebergen Drug Corporation for 110 mg vials of artesunate. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 17, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order was issued to procure medical supplies in support of DLA programs. No...
- The Defense Logistics Agency's Medical Supply Chain awarded a $1,238.07 delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for Coartem Tablets 24S, an antimalarial medication commonly used for treatment of malaria in military and defense health applications. This non-competitive, firm fixed-price delivery order, which is due for completion by April 24, 2025, represents a discrete purchase against AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support...
- This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,069.37, is for the delivery of the pharmaceutical product Artesunat 110mg 2s. This is a firm-fixed-price delivery order contract with a completion date of May 16, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,593.63 to supply 100 tablets of Malarone 250-100 mg, an antimalarial medication. The award, issued on December 17, 2025, with completion by December 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,562.33 to AmerisourceBergen Drug Corp for Coartem Tablets 24S, a pharmaceutical product used in malaria treatment. The contract is non-competitive and employs firm fixed-price pricing, with a completion date of January 9, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...